Description

HbA1c reflects average blood glucose over approximately 8–12 weeks, providing a stable index for diabetes control beyond day‑to‑day fluctuations. It helps assess therapy effectiveness and the risk of complications affecting eyes, kidneys, nerves and heart. No fasting is required. For newly detected diabetes, clinicians may use HbA1c to set targets and track progress. It complements FBS and PPBS, offering long‑term perspective for individualized treatment decisions and lifestyle planning.